Products for Research Use Only
RegisterLogin

Acalabrutinib

CAT: 0026-B1193-25Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0026-B1193-25Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Acalabrutinib (ACP-196) is an orally available, selective irreversible inhibitor of Bruton’s tyrosine kinase (BTK) with potential antineoplastic activity. It is a second generation BTK inhibitor with improved pharmacological properties with better plasma exposure, oral absorption and shorter half-life. It prevents the activation of B-cell antigen receptor (BCR) signaling pathway, thus preventing B-cell activation and BTK mediated activation of downstream survival pathways.
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months

Alternative Products

CatalogName
FA138815-01Acalabrutinib
HY-17600R-01Acalabrutinib (Standard)
AR-A05277-01Acalabrutinib-d4
BUP12133-01Acalabrutinib enantiomer
AR-A08073-01R-Acalabrutinib
HY-W757743Acalabrutinib-d3

Popular Products